Drug Treats Painful Side Effect of Chemotherapy
Posted on: Thursday, 16 December 2004, 21:00 CST
THURSDAY, Dec. 16 (HealthDayNews) -- The U.S. Food and Drug Administration has approved the Amgen intravenous drug Kepivance (palifermin) to prevent mucositis, a common side effect among blood cancer patients who have chemotherapy before bone marrow transplants.
Patients with mucositis, characterized by debilitating, painful sores in the lining of the mouth and throat, often have trouble eating, drinking and swallowing.
Some 11,000 adults with hematologic cancers -- including non-Hodgkin's lymphoma, Hodgkin's disease, leukemia and multiple myeloma -- have bone marrow transplants each year, Amgen said. The new drug works to stimulate the growth of cells in the mouth and throat that protect tissue from the harmful effects of chemotherapy and/or radiation.
The most common side effects of Kepivance use were skin rash, tingling sensations in the mouth and throat, and an increase in certain blood proteins that signal pancreatic irritation. None of these conditions is considered serious, the FDA said.
More information
For more information about mucositis, visit the National Cancer Institute.
~-LEU~~-GEN~~FDA-~
Source: HealthSCOUT
Related Articles
- The GI Company Reports Additional Phase II Clinical Data of Intestinal Trefoil Factor (rhITF) Oral Spray for Oral Mucositis
- The GI Company Reports Significant Reduction in Occurrence of Oral Mucositis in Phase II Study Presented at ASCO
- The GI Company Reports Significant Reduction in Occurrence of Oral Mucositis in Phase II Study; Abstract Posted Online at ASCO.Org
- The GI Company to Present Phase I &Amp; II Oral Mucositis Data at MASCC / ISOO Annual Meeting
- The GI Company to Present Phase II Oral Mucositis Data at ASCO Annual Meeting
- Engineers Building Drug Filled Tooth
- Advancis Tests 1-a-Day Strep-Throat Drug
- Durham, N.C., Development Firm Gets $30 Million, Drug Rights
- The Pink Issue: Your Health - Reduce YOUR Risk ; Are You Worried About Contracting Breast Cancer? The Strongest Risk Factor is Age the Older You Get, the More Likely Cancer Will Affect You. But There Are Some Important Steps You Can Take Throughout Your
- Scandinavian Formulas: FDA Issues OTC Drug Status for a New Saliva-Stimulating Lozenge
 |
 |
User Comments (0)
RSS Feeds